Advanced Plant Pharmaceuticals, Inc.'s Marketing Partner Signs First European Distributor For Lo-Chol in Portugal and Spain

Nutralife Pharmaceuticals, Inc. Building International Marketing Network For Lo-Chol

NEW YORK, Nov 4, 2003 (BUSINESS WIRE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI), a company that utilizes whole plants through a proprietary (patent pending) manufacturing process to develop all-natural Whole Plant Pharmaceuticals and Nutritionals, announced that the company's exclusive marketing partner for Lo-Chol, Nutralife Pharmaceuticals. Inc. has signed an exclusive distribution agreement with the largest direct response television, catalog & retail distribution company in Spain for the marketing territories of Spain and Portugal.

In order to maintain its distribution exclusivity for Lo-Chol in Spain and Portugal, the distributor will purchase a minimum of 100,000 units of Lo-Chol. APPI's patented cholesterol reducing dietary supplement, over the next twelve months from Nutra-Life Pharmaceuticals, Inc. for resale.

Jeffrey Glickman, CEO of Nutralife Pharmaceuticals, said,"We are excited about our first European distributor joining the international distribution network we are building for Lo-Chol. In addition, Nutralife is in active negotiations with several other international distributors to continue to expand Lo-Chol's availability worldwide. With Lo-Chol's unique, proprietary properties for the reduction of cholesterol, we are confident of Lo-Chol's potential to compete in the estimated $30 Billion worldwide cholesterol-lowering market."

"We are very encouraged by the rapid progress Nutralife Pharmaceuticals is making with the marketing and distribution of Lo-Chol", said David Lieberman, CEO of Advanced Plant Pharmaceuticals, Inc. "When the infomercials for Lo-Chol, hosted by Mr. Ed McMahon, begin to be aired soon, we anticipate that the increased public awareness of Lo-Chol will generate significant increases in Lo-Chol sales both domestically and internationally."

Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of plant-based dietary supplements. The Company has a patent pending process that utilizes whole plants to manufacture all natural dietary supplements. APPI uses this process to manufacture products, which the company plans to distribute worldwide through various sales distribution contracts or majority-owned spin-off companies. Current products include Sinusol (homeopathic allergy and nasal spray), Garlic, ACA (immune system booster) and the patented Lo-Chol. Corporate website:

NutraLife Pharmaceuticals, Corp. is a newly established direct response and marketing firm focused on the development and design of marketing programs for a range of commercial products, including production, media buying, fulfillment, direct response, telemarketing, customer service and retail integration and distribution.


This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.